Panuveitis: Clinical Trials

20 trials for Panuveitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 7 unknown, 2 not yet recruiting, 2 withdrawn. 20 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 420Completed 7, Unknown 7, Not yet recruiting 2, Withdrawn 2, Active not recruiting 1, Terminated 1

Follow Panuveitis: new trials by email Literature Review of Panuveitis trials Research Report on Panuveitis

Trials (filtered) newest first · largest first

All 20 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adalimumab Dose Adjustment for Pediatric Uveitis Treatment Trial
Adalimumab/Biosimilar - Juvenile Idiopathic Arthritis Associated Uveitis, Uveitis, Anterior
Phase 4Not yet recruitingNisha Acharya1602026-09-012026-07-13
Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis
Upadacitinib 15 MG [Rinvoq] - Axial Spondylarthritis (axSpA)
Phase 4Not yet recruitingCARE ARTHRITIS LTD.2002026-05-012026-02-06
Loteprednol Etabonate Versus Prednisolone Acetate for Anterior Chamber Granulomas
loteprednol etabonate 1% arm 1, prednisolone acete 1% - Anterior Chamber Granulomatous Uveitis
Phase 4CompletedFayoum University662025-08-102026-03-27
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
Recombinant Herpes Zoster Vaccine (RZV), MTX Discontinuation, MMF Discontinuation - Rheumatoid Arthritis, Spondylitis, Ankylosing
Phase 4Active not recruitingUniversity of Sao Paulo General Hospital20052023-05-232026-05-04
A Study of the Effect of Different Doses of Difluprednate Eye Drops on the Intraocular Pressure After Phacoemulsification
Difluprednate Eye Drops - Uveitis, Anterior
Phase 4UnknownKafrelsheikh University202022-11-012022-12-13
Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis
Fluocinolone Acetonide Intravitreal Implant 0.18 mg - Uveitis, Posterior
Phase 4UnknownAlimera Sciences1252022-06-062024-08-06
Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study
Ixekizumab Prefilled Syringe - Uveitis, Posterior, Uveitis, Anterior
Phase 4UnknownMassachusetts Eye Research and Surgery Institution202022-06-012023-10-16
Ozurdex Monotherapy Trial
Ozurdex 0.7mg Ophthalmic Implant, Prednisone - Uveitis, Posterior, Uveitis, Intermediate
Phase 4WithdrawnOttawa Hospital Research Institute2021-11-302025-03-12
The Efficacy and Safety of Adalimumab in Non-infectious Anterior Pediatric Uveitis With Peripheral Vascular Leakage
Adalimumab, Methotrexate - Uveitis, Anterior, Adalimumab
Phase 4UnknownPeking Union Medical College Hospital502021-08-192021-11-10
Six-months Versus Nine-months ATT for Ocular TB
Anti-Tuberculosis Treatment - Tuberculosis (TB), Uveitis
Phase 4CompletedL.V. Prasad Eye Institute582020-01-012024-09-26
Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)
Acthar Gel - Uveitis, Posterior, Uveitis, Intermediate
Phase 4TerminatedMallinckrodt52018-10-052021-08-03
Saline vs. Lactated Ringers for Emergency Department IV Fluid Resuscitation
Lactated Ringer Solution, Normal Saline 0.9% Infusion Solution Bag - Fluid Loss, Symptom Complex, Triple
Phase 4CompletedNicholas M Mohr1572017-05-232018-09-11
Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis
H.P. ACTHAR GEL - Uveitis, Posterior, Vasculitis Retinal
Phase 4UnknownOcular Immunology and Uveitis Foundation402017-03-222019-09-12
A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AU
Certolizumab Pegol - Axial Spondyloarthritis (axSpA), Anterior Uveitis (AU)
Phase 4CompletedUCB Biopharma SRL892016-12-212026-06-23
Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients
H.P. ACTHAR SUBCUTANEOUS GEL INJECTION - Uveitis, Anterior Uveitis
Phase 4CompletedTampa Bay Uveitis Center, LLC62016-06-302018-07-02
Study of the Effectiveness of Ozurdex for the Control of Uveitis
Dexamethasone pellet - Uveitis, Intermediate, Uveitis, Posterior
Phase 4CompletedJohns Hopkins University202014-01-012019-07-05
Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG
travoprost and timolol maleate fixed combination, latanoprost and maleate timolol fixed combination, bimatoprost and timolol maleate fixed combination - Uveitis, Anterior, Cystoid Macular Edema
Phase 4CompletedUniversity of Campinas, Brazil692011-10-012013-11-07
The Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease
methylorednisolone, dextrose water 5% - Behcet's Disease
Phase 4UnknownTehran University of Medical Sciences342010-02-012011-03-02
Flucinolone Acetonide Implant for Treating Refractory Ocular Behcet's Disease
flucinolone acetonide - Ocular Behcet's Disease,, Non-Infectious Uveitis
Phase 4UnknownAsan Medical Center152008-07-012008-07-29
Methotrexate in the Treatment of Axial Spondyloarthritis
Methotrexate - Spondylarthropathies, Spondylitis, Ankylosing
Phase 4WithdrawnRheumatism Foundation Hospital1202006-03-012009-01-05

Narrower conditions

Uveitis, Anterior (10)  ·  Uveitis, Posterior (9)  ·  Uveitis, Intermediate (6)  ·  Behcet Syndrome (4)  ·  Uveitis (4)  ·  Retinal Vasculitis (3)  ·  Axial Spondyloarthritis (2)  ·  Spondylitis, Ankylosing (2)  ·  Arthritis, Juvenile (1)  ·  Arthritis, Rheumatoid (1)  ·  Choroiditis (1)  ·  Dermatomyositis (1)  ·  Emergencies (1)  ·  Eye Abnormalities (1)

Broader conditions

Uveal Diseases (20)  ·  Eye Diseases (19)  ·  Uveitis (16)  ·  Cardiovascular Diseases (6)  ·  Vascular Diseases (6)  ·  Vasculitis (6)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  Ankylosis (4)  ·  Arthritis (4)  ·  Bone Diseases (4)  ·  Genetic Diseases, Inborn (4)  ·  Hereditary Autoinflammatory Diseases (4)  ·  Joint Diseases (4)  ·  Mouth Diseases (4)

Interventions

Adalimumab (2)  ·  Adrenocorticotropic Hormone (2)  ·  Fluocinolone Acetonide (2)  ·  Methotrexate (2)  ·  Bimatoprost (1)  ·  Biosimilar Pharmaceuticals (1)  ·  Calcium Dobesilate (1)  ·  Certolizumab Pegol (1)  ·  Dextrans (1)  ·  Ganfort (1)  ·  Hypromellose Derivatives (1)  ·  Latanoprost (1)  ·  Loteprednol Etabonate (1)  ·  Prednisone (1)  ·  Ringer's Lactate (1)

Sponsors

Alimera Sciences (1)  ·  Asan Medical Center (1)  ·  CARE ARTHRITIS LTD. (1)  ·  Fayoum University (1)  ·  Johns Hopkins University (1)  ·  Kafrelsheikh University (1)  ·  L.V. Prasad Eye Institute (1)  ·  Mallinckrodt (1)  ·  Massachusetts Eye Research and Surgery Institution (1)  ·  Nicholas M Mohr (1)  ·  Nisha Acharya (1)  ·  Ocular Immunology and Uveitis Foundation (1)  ·  Ottawa Hospital Research Institute (1)  ·  Peking Union Medical College Hospital (1)  ·  Rheumatism Foundation Hospital (1)

Countries

United States (9)  ·  Brazil (2)  ·  Egypt (2)  ·  Burma (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)  ·  Finland (1)  ·  Germany (1)  ·  India (1)  ·  Iran (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  South Korea (1)

Top investigators

Ahmed Hashem, PhD (1)  ·  Alana M Santana, MD (1)  ·  Antonio Cutino (1)  ·  C. Stephen Foster, MD, FACS, FACR (1)  ·  Farhad Shahram, Professor (1)  ·  Grace L Clarke (1)  ·  Jennifer E Thorne, MD, PhD (1)  ·  Matti Laitinen, MD (1)  ·  Meifen Zhang, MD (1)  ·  Nisha Acharya, MD MS (1)  ·  Walter Maksymowych, Dr. (1)  ·  Young Hee Yoon, MD (1)

Results publications

PMID 28445659, PMID 30146446, PMID 33854572, PMID 36600374, PMID 41679320, PMID 41919656, PMID 41932224, PMID 42261247, PMID 42294825, PMID 42843284

NIH funding

2005 (1), 2016 (1), UG1EY038172 (1)